Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ATL-001 by Achilles Therapeutics for Metastatic Melanoma: Likelihood of Approval
ATL-001 is under clinical development by Achilles Therapeutics and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase...
Data Insights
Risk adjusted net present value: What is the current valuation of Achilles Therapeutics's ATL-001?
ATL-001 is a cell therapy commercialized by Achilles Therapeutics, with a leading Phase II program in Metastatic Melanoma. According to...